Focused Wealth Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Focused Wealth Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,750	Closed	-$31K	–	778
2018 Q3	$31K	Hold	1,750	–	–	0.01%	336
2018 Q2	$24K	Buy	+1,750	New	+$20.8K	0.01%	342

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Focused Wealth Management's ECYT Position: Q4 2018 in Review

Focused Wealth Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 1,750 shares — an estimated $31K sold.

Focused Wealth Management first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $31K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Focused Wealth Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Focused Wealth Management sold 1,750 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $31K.
Focused Wealth Management first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Focused Wealth Management's Endocyte, Inc. Common Stock position peaked at $31K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Focused Wealth Management's 13F filing for Q4 2018, filed 30 Jan 2019.